drugset / Trial / NCT01229228

Study of Naproxen Capsules to Treat Dental Pain

NCT01229228

Phase 2 Completed 254 enrolled Iroko Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether Naproxen Test Formulation Capsules are safe and effective for the treatment of dental pain.

Timeline

Start
2010-10
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule 200 mg
Subject Naproxen Small molecule 250 mg
Subject Naproxen Small molecule 400 mg
Subject Naproxen Small molecule 500 mg

Indications

No indication recorded.